Free Trial

OnKure Therapeutics Q1 2023 Earnings Report

OnKure Therapeutics logo
$8.61 -0.12 (-1.37%)
(As of 12/18/2024 05:44 PM ET)

OnKure Therapeutics EPS Results

Actual EPS
-$6.00
Consensus EPS
-$6.30
Beat/Miss
Beat by +$0.30
One Year Ago EPS
N/A

OnKure Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OnKure Therapeutics Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Trump’s Sending THIS Crypto Higher on Purpose (Ad)

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

OnKure Therapeutics Earnings Headlines

Oppenheimer Remains a Buy on OnKure Therapeutics (OKUR)
OnKure Therapeutics announces safety, pharmacokinetic data on OKI-219
Forbes rich list released… #1 to be assassinated?
Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.
OnKure Therapeutics Advances Cancer Drug Trials
See More OnKure Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OnKure Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OnKure Therapeutics and other key companies, straight to your email.

About OnKure Therapeutics

Reneo Pharmaceuticals Inc.is a clinical stage pharmaceutical company. It is focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases. Reneo Pharmaceuticals Inc.is based in SAN DIEGO.

View OnKure Therapeutics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings